Compare IONQ Inc (IONQ) vs Medtronic PLC (MDT) Price & Performance

IONQ trades at $34.24, down 1.55% on the day amid a broader tech sell-off. The stock is technically bearish with key support at $31, while oscillators suggest potential oversold conditions. Fundamentally, the company shows strong revenue growth projections from $130M in 2025 to $187M in 2026, but remains unprofitable with a net loss of $510M in 2025. Recent news highlights IonQ's leadership in quantum computing but notes significant stock volatility and competitive threats.

The outlook for IonQ is bifurcated: long-term growth potential in quantum computing is substantial, supported by a $73.75 analyst price target, but high valuation multiples and persistent losses pose near-term risks. Investment opportunity hinges on execution of its technology roadmap, while risks include cash burn, competitive pressures, and market sentiment shifts toward speculative tech stocks.

Medtronic (MDT) trades at $82.35, down 1.02% on the day, with a bullish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS expected at $1.39. Revenue grew to $33.54B in 2025, with a net income margin of 13.2%. Recent news highlights the acquisition of SPR and the launch of AI-powered surgical technology, signaling innovation-driven growth.

The outlook for MDT is positive, supported by analyst consensus with a $97.50 price target and 58% buy ratings. Key opportunities include robust cash flow and dividend stability, while risks involve rising debt levels and competitive pressures in medtech. The stock presents a value proposition with a P/E of 22.33, trading below the consensus target.